• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Med Genomics . Revealing differential expression patterns of piRNA in FACS blood cells of SARS-CoV-2 infected patients

tetano

Editor, Senior Moderator
BMC Med Genomics


. 2024 Aug 14;17(1):212.
doi: 10.1186/s12920-024-01982-9. Revealing differential expression patterns of piRNA in FACS blood cells of SARS-CoV-2 infected patients

Kirill A Kondratov[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Alexander A Artamonov[SUP] #[/SUP][SUP] 4 [/SUP], Yuri V Nikitin[SUP] 4 [/SUP], Anastasiya A Velmiskina[SUP] 5 6 [/SUP], Vladimir Yu Mikhailovskii[SUP] 6 [/SUP], Sergey V Mosenko[SUP] 5 6 [/SUP], Irina A Polkovnikova[SUP] 5 6 [/SUP], Anna Yu Asinovskaya[SUP] 5 6 [/SUP], Svetlana V Apalko[SUP] 5 6 [/SUP], Natalya N Sushentseva[SUP] 5 [/SUP], Andrey M Ivanov[SUP] 4 [/SUP], Sergey G Scherbak[SUP] 5 6 [/SUP]



Affiliations
Abstract

Non-coding RNA expression has shown to have cell type-specificity. The regulatory characteristics of these molecules are impacted by changes in their expression levels. We performed next-generation sequencing and examined small RNA-seq data obtained from 6 different types of blood cells separated by fluorescence-activated cell sorting of severe COVID-19 patients and healthy control donors. In addition to examining the behavior of piRNA in the blood cells of severe SARS-CoV-2 infected patients, our aim was to present a distinct piRNA differential expression portrait for each separate cell type. We observed that depending on the type of cell, different sorted control cells (erythrocytes, monocytes, lymphocytes, eosinophils, basophils, and neutrophils) have altering piRNA expression patterns. After analyzing the expression of piRNAs in each set of sorted cells from patients with severe COVID-19, we observed 3 significantly elevated piRNAs - piR-33,123, piR-34,765, piR-43,768 and 9 downregulated piRNAs in erythrocytes. In lymphocytes, all 19 piRNAs were upregulated. Monocytes were presented with a larger amount of statistically significant piRNA, 5 upregulated (piR-49039 piR-31623, piR-37213, piR-44721, piR-44720) and 35 downregulated. It has been previously shown that piR-31,623 has been associated with respiratory syncytial virus infection, and taking in account the major role of piRNA in transposon silencing, we presume that the differential expression patterns which we observed could be a signal of indirect antiviral activity or a specific antiviral cell state. Additionally, in lymphocytes, all 19 piRNAs were upregulated.

Keywords: Basophils; Blood cells; Eosinophils; Erythrocytes; Lymphocytes; Monocytes; Neutrophils; Next generation sequencing of smallRNAs; Severe COVID−19; piRNA.

 
Back
Top Bottom